VERE is a specialist medical practice in Genk. Public Limited, started on 18 December 1986, 1 establishment.

What is the address of VERE?

The registered office of VERE is located at Weg naar As 123, 3600 Genk.

Is VERE still active?

Yes. According to the CBE (29 October 2026) VERE is active, legal situation “Normale toestand”, started on 18 December 1986.

Is VERE registered on Peppol?

Yes, VERE is registered on the Peppol network with ID 0208:0430067217.

What is the enterprise number of VERE?

The enterprise number of VERE is BE0430067217.

When was VERE founded?

VERE was founded on 18 December 1986.

Who are the directors of VERE?

According to the 2025 annual accounts, the directors of VERE are: Anneleen Remans, Petra Remans, Roseline Remans.

Is VERE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 18 December 1986; 5 annual accounts filed, latest fiscal year 2025; 3 directors known from the annual account.

How much profit did VERE make in 2025?

VERE posted a profit after taxes of € 148,623 in financial year 2025.

What is the revenue of VERE?

As a small company, VERE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 457,762.

VERE (Public Limited) - Genk - BE0430067217

Dossier VERE, printed on 29 October 2026 from databakkes.be/en/0430067217/vere. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 6 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

VERE from Genk, company number BE0430067217, closed financial year 2025 with a result of € 148,623 after tax. For that financial year VERE recorded a gross margin of € 457,762 and equity of € 1.4 million. Compared with financial year 2024, the result moved from € 171,702 to € 148,623. The company is profitable. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on September 22, 2026.

What it is worth Growing

€ 1.4 million

▲ 12% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 148,623

▼ 13% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 26,383

▲ € 26,303 vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 1.1 million.

People and assets in 2025

Vehicles and equipment

€ 20,504

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

€ 2.5 million

▼ 7% vs 2024

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 46,989

▼ 3% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 33,225

▲ € 32,826 vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 123,758 Gross margin 2022: € 123,758 First fiscal year in the series	€ 260,917 Gross margin 2023: € 260,917 ▲ 111% vs 2022 (€ 123,758) Favourable step	€ 419,503 Gross margin 2024: € 419,503 ▲ 61% vs 2023 (€ 260,917) Favourable step	€ 457,762 Gross margin 2025: € 457,762 ▲ 9% vs 2024 (€ 419,503) Favourable step	▲ 9%
Profit after taxes	€ -28,500 Profit after taxes 2022: € -28,500 First fiscal year in the series	€ 222,520 Profit after taxes 2023: € 222,520 ▲ € 251,019 vs 2022 (€ -28,500) Favourable step	€ 171,702 Profit after taxes 2024: € 171,702 ▼ 23% vs 2023 (€ 222,520) Unfavourable step	€ 148,623 Profit after taxes 2025: € 148,623 ▼ 13% vs 2024 (€ 171,702) Unfavourable step	▼ 13%
Equity	€ 1,411,393 Equity 2022: € 1,411,393 First fiscal year in the series	€ 1,033,913 Equity 2023: € 1,033,913 ▼ 27% vs 2022 (€ 1,411,393) Unfavourable step	€ 1,205,615 Equity 2024: € 1,205,615 ▲ 17% vs 2023 (€ 1,033,913) Favourable step	€ 1,354,239 Equity 2025: € 1,354,239 ▲ 12% vs 2024 (€ 1,205,615) Favourable step	▲ 12%
Total debts	€ 2,251,791 Total debts 2022: € 2,251,791 First fiscal year in the series	€ 3,807,572 Total debts 2023: € 3,807,572 ▲ 69% vs 2022 (€ 2,251,791) Unfavourable step	€ 3,505,898 Total debts 2024: € 3,505,898 ▼ 8% vs 2023 (€ 3,807,572) Favourable step	€ 3,234,399 Total debts 2025: € 3,234,399 ▼ 8% vs 2024 (€ 3,505,898) Favourable step	▼ 8%
Cash	€ 443,577 Cash 2022: € 443,577 First fiscal year in the series	€ 23,944 Cash 2023: € 23,944 ▼ 95% vs 2022 (€ 443,577) Unfavourable step	€ 80 Cash 2024: € 80 ▼ € 23,865 vs 2023 (€ 23,944) Unfavourable step	€ 26,383 Cash 2025: € 26,383 ▲ € 26,303 vs 2024 (€ 80) Favourable step	▲ € 26,303
Land & buildings	€ 293,228 Land & buildings 2022: € 293,228 First fiscal year in the series	€ 4,735,157 Land & buildings 2023: € 4,735,157 ▲ € 4.4 million vs 2022 (€ 293,228) Unchanged	€ 4,611,310 Land & buildings 2024: € 4,611,310 ▼ 3% vs 2023 (€ 4,735,157) Unchanged	€ 4,461,077 Land & buildings 2025: € 4,461,077 ▼ 3% vs 2024 (€ 4,611,310) Unchanged	▼ 3%
Retained profit	€ 511,393 Retained profit 2022: € 511,393 First fiscal year in the series	€ 733,913 Retained profit 2023: € 733,913 ▲ 44% vs 2022 (€ 511,393) Favourable step	€ 905,615 Retained profit 2024: € 905,615 ▲ 23% vs 2023 (€ 733,913) Favourable step	€ 1,054,239 Retained profit 2025: € 1,054,239 ▲ 16% vs 2024 (€ 905,615) Favourable step	▲ 16%
Bank debt	€ 1,419,419 Bank debt 2022: € 1,419,419 First fiscal year in the series	€ 2,893,948 Bank debt 2023: € 2,893,948 ▲ 104% vs 2022 (€ 1,419,419) Unfavourable step	€ 2,735,855 Bank debt 2024: € 2,735,855 ▼ 5% vs 2023 (€ 2,893,948) Favourable step	€ 2,549,168 Bank debt 2025: € 2,549,168 ▼ 7% vs 2024 (€ 2,735,855) Favourable step	▼ 7%
Balance sheet total	€ 3,846,678 Balance sheet total 2022: € 3,846,678 First fiscal year in the series	€ 4,841,485 Balance sheet total 2023: € 4,841,485 ▲ 26% vs 2022 (€ 3,846,678) Unchanged	€ 4,711,513 Balance sheet total 2024: € 4,711,513 ▼ 3% vs 2023 (€ 4,841,485) Unchanged	€ 4,588,637 Balance sheet total 2025: € 4,588,637 ▼ 3% vs 2024 (€ 4,711,513) Unchanged	▼ 3%

Key figures of VERE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to VERE?

What happened at VERE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

2028 Anneleen Remans stepped down as director. NBB
2028 Petra Remans stepped down as director. NBB
2028 Roseline Remans stepped down as director. NBB
Sep 22, 2026 New annual accounts for financial year 2025: profit of € 148,623 (▼ 13% vs 2024). filed late Source: NBB ↗
2022 Anneleen Remans became a director. NBB
2022 Petra Remans became a director. NBB
2022 Roseline Remans became a director. NBB
Jan 26, 1987 New establishment in Genk. KBO

In short

From € 28,500 loss in 2022 to € 148,623 profit in 2025.

Paid € 69,233 in corporate taxes since 2022.

Best year ever: 2023, with € 222,520 profit.

Original PDFs at the National Bank ↗

Management

Directors

According to the 2025 annual accounts

Anneleen Remans

Director

since 2022 · until 2028

Petra Remans

Director

since 2022 · until 2028

Roseline Remans

Director

since 2022 · until 2028

Establishments

Establishment units

Physical locations of this company

Registered office

Weg naar As 123

3600 Genk

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 5 companies are registered at this address.

All companies at this address →

MEDISCH CENTRUM GENK

€ 859,250 gross margin · 2025

MAATSCHAP MARJAN

GLOCOLEARNING

€ 39,407 gross margin · 2025

DRS. REMANS REUMATOLOGIE

€ 463,548 gross margin · 2025

Boelhouwers Reumatologie

€ 113,047 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0430.067.217
VAT number: BE 0430.067.217
Registered office: Weg naar As 123, 3600 Genk
Names & denominations: VERE
Enterprise type: Rechtspersoon
Legal form: Public limited company
Legal situation: Normale toestand
Start date: 18 December 1986
Peppol: Active · Active since 22 Dec 2025
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗

VERE

Warning lights

Financials

What happened to VERE?

Management

Directors

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions